Chemical Modification of Class II G Protein-Coupled Receptor Ligands: Frontiers in the Development of Peptide Analogs as Neuroendocrine Pharmacological Therapies
Pharmacology and Therapeutics - United Kingdom
doi 10.1016/j.pharmthera.2009.07.006
Full Text
Open PDFAbstract
Available in full text
Categories
Date
January 1, 2010
Authors
Publisher
Elsevier BV